Literature DB >> 20188853

Evaluation of a liver micronucleus assay in young rats (III): a study using nine hepatotoxicants by the Collaborative Study Group for the Micronucleus Test (CSGMT)/Japanese Environmental Mutagen Society (JEMS)-Mammalian Mutagenicity Study Group (MMS).

Hironao Takasawa1, Hiroshi Suzuki, Izumi Ogawa, Yasushi Shimada, Kazuo Kobayashi, Yukari Terashima, Hirotaka Matsumoto, Chinami Aruga, Keiyu Oshida, Ryo Ohta, Tadashi Imamura, Atsushi Miyazaki, Masayoshi Kawabata, Shigenori Minowa, Makoto Hayashi.   

Abstract

We have been investigating a liver micronucleus assay to detect genotoxic chemicals using young rats for several years, and had established its advantages with respect to using autonomous proliferation of young rat hepatocytes. Nine chemicals known to induce hepatotoxic effects such as necrosis (2,6-dinitrotolune, bromobenzene, isoniazid, phenacetin, allyl alcohol and thioacetamide), cholestasis (chlorpromazine hydrochloride and alpha-naphthyl isothiocyanate) and oxidative stress (clofibrate) were selected for this study. A liver micronucleus assay was conducted in 4-week-old male F344 rats using two or three dose levels of test chemicals given orally by gavage to evaluate the compound's ability to induce micronucleated hepatocytes. Several of these test chemicals were additionally examined in a peripheral blood micronucleus assay conducted concurrently and in the same animals. The genotoxic rodent hepatocarcinogen, 2,6-dinitrotoluene showed a positive result in the liver micronucleus assay, but the nongenotoxic hepatocarcinogens, clofibrate and thioacetamide gave negative responses. Bromobenzene, known to produce DNA adducts but is noncarcinogenic in rodent liver, was judged equivocal in this assay. alpha-Naphthyl isothiocyanate is noncarcinogenic and showed negative response in the liver. The other four chemicals, known to be either noncarcinogenic or carcinogenic in other non-liver target organs, showed negative results in the liver micronucleus assay. Based on the results in the present study and previous report described above, it was concluded that this technique is able to effectively predict genotoxic rodent hepatocarcinogenicity, and does not give false positives due to hepatotoxicity. Copyright 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20188853     DOI: 10.1016/j.mrgentox.2010.02.009

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  5 in total

1.  Effectiveness of the liver micronucleus assay using juvenile mice.

Authors:  Ritsuko Nagasue; Ikue Murata; Kazuaki Sasaki; Rina Sakai; Hirofumi Miyajima; Minoru Shimoda
Journal:  J Vet Med Sci       Date:  2017-07-11       Impact factor: 1.267

2.  Evaluation of the novel liver micronucleus assay using formalin-fixed tissues.

Authors:  Shuichi Hamada; Miyuki Shigano; Satoru Kawakami; Maya Ueda; Hajime Sui; Katsuya Yamada; Soichiro Hagio; Ayaka Momonami; Akihisa Maeda; Yukari Terashima; Wakako Ohyama; Takeshi Morita; Makoto Hayashi
Journal:  Genes Environ       Date:  2019-05-09

3.  Detection of hepatocarcinogens by combination of liver micronucleus assay and histopathological examination in 2-week or 4-week repeated dose studies.

Authors:  Shuichi Hamada; Miyuki Shigano; Yumi Wako; Kazufumi Kawasako; Kensuke Satomoto; Tatsuya Mitsumoto; Takayuki Fukuda; Wakako Ohyama; Takeshi Morita; Makoto Hayashi
Journal:  Genes Environ       Date:  2022-01-04

4.  A toxicogenomic approach for the prediction of murine hepatocarcinogenesis using ensemble feature selection.

Authors:  Johannes Eichner; Nadine Kossler; Clemens Wrzodek; Arno Kalkuhl; Dorthe Bach Toft; Nina Ostenfeldt; Virgile Richard; Andreas Zell
Journal:  PLoS One       Date:  2013-09-10       Impact factor: 3.240

5.  Tissue-specific in vivo genetic toxicity of nine polycyclic aromatic hydrocarbons assessed using the Muta™Mouse transgenic rodent assay.

Authors:  Alexandra S Long; Christine L Lemieux; Volker M Arlt; Paul A White
Journal:  Toxicol Appl Pharmacol       Date:  2015-11-18       Impact factor: 4.219

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.